SCHEMBL563659

SCHEMBL563659

CCCCCc1cc(O)cc(=O)o1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
MAPT P10636 2/20 0.53
ELANE P08246 3/20 0.49
PTGS2 P35354 3/20 0.48
CYP3A4 P08684 2/20 0.48
MEN1 O00255 2/20 0.48
ALDH1A1 P00352 2/20 0.48
GAA P10253 2/20 0.48
KMT2A Q03164 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MAPK1 P28482 1/20 0.48
GPR84 Q9NQS5 7/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 1/20 0.46
GLA P06280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6911145 0.98 MAPT (0.56) ALOX15SMN1; SMN2MAPTELANEPTGS2
SCHEMBL6907126 0.98 MAPT (0.56) ALOX15SMN1; SMN2MAPTELANEPTGS2
SCHEMBL6913197 0.98 MAPT (0.56) ALOX15SMN1; SMN2MAPTELANEPTGS2
SCHEMBL6914193 0.98 MAPT (0.56) ALOX15SMN1; SMN2MAPTELANEPTGS2
SCHEMBL6911155 0.98 MAPT (0.56) ALOX15SMN1; SMN2MAPTELANEPTGS2
SCHEMBL6910732 0.98 MAPT (0.56) ALOX15SMN1; SMN2MAPTELANEPTGS2
SCHEMBL6912180 0.98 MAPT (0.56) ALOX15SMN1; SMN2MAPTELANEPTGS2
SCHEMBL6905774 0.98 MAPT (0.56) ALOX15SMN1; SMN2MAPTELANEPTGS2
SCHEMBL6912499 0.98 MAPT (0.56) ALOX15SMN1; SMN2MAPTELANEPTGS2
SCHEMBL6916585 0.98 MAPT (0.56) ALOX15SMN1; SMN2MAPTELANEPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122005859-A Application of FKBP12B in improving silkworm survival rate and silk quality 浙江理工大学 2026-05-12 CN claimed
EP-4603924-A1 TIMEPIECE AXIS MADE OF AN INTERMETALLIC MATERIAL Richemont International S.A. (CH) 2025-08-20 EP claimed
CN-120024901-A Method for reducing carbon element content in electronic grade polysilicon in reduction process 昆明理工大学 2025-05-23 CN claimed
US-20240240160-A1 NOVEL OLIVETOL SYNTHASES FOR CANNABINOID PRODUCTION CREO INGREDIENTS, INC. 2024-07-18 US claimed
CN-117660811-A PdAL electrocatalyst with tip enrichment effect and preparation method and application thereof 中国人民解放军空军勤务学院 2024-03-08 CN claimed
US-20240052332-A1 OLIVETOLIC ACID CYCLASE VARIANTS AND METHODS FOR THEIR USE CREO INGREDIENTS, INC. 2024-02-15 US claimed
CN-116758223-A Three-dimensional multispectral point cloud reconstruction method, system and equipment based on double-angle multispectral image 哈尔滨工业大学 2023-09-15 CN claimed
US-20230167468-A1 CANNABINOID SYNTHASE VARIANTS AND METHODS FOR THEIR USE CREO INGREDIENTS, INC. 2023-06-01 US claimed
EP-4136220-A1 CANNABINOID SYNTHASE VARIANTS AND METHODS FOR THEIR USE Genomatica, Inc. (US) 2023-02-22 EP claimed
CN-111857757-B Container cloud-based efficient deployment method for aerial image processing service 上海方联技术服务有限公司 2023-02-10 CN claimed
CN-115450792-A Control method and system for civil aviation scaling turbofan engine 北京航空航天大学杭州创新研究院 2022-12-09 CN claimed
US-20220315969-A1 OLIVETOLIC ACID CYCLASE VARIANTS AND METHODS FOR THEIR USE CREO INGREDIENTS, INC. 2022-10-06 US claimed
EP-4025705-A2 PRENYLTRANSFERASE VARIANTS AND METHODS FOR PRODUCTION OF PRENYLATED AROMATIC COMPOUNDS Genomatica, Inc. (US) 2022-07-13 EP claimed
WO-2022125645-A1 OLIVETOLIC ACID CYCLASE VARIANTS AND METHODS FOR THEIR USE GENOMATICA, INC. (US) 2022-06-16 WO claimed
US-20220177858-A1 OLIVETOL SYNTHASE VARIANTS AND METHODS FOR PRODUCTION OF OLIVETOLIC ACID AND ITS ANALOG COMPOUNDS CREO INGREDIENTS, INC. 2022-06-09 US claimed
EP-3980520-A1 OLIVETOLIC ACID CYCLASE VARIANTS AND METHODS FOR THEIR USE Genomatica, Inc. (US) 2022-04-13 EP claimed
EP-3956462-A1 OLIVETOL SYNTHASE VARIANTS AND METHODS FOR PRODUCTION OF OLIVETOLIC ACID AND ITS ANALOG COMPOUNDS Genomatica, Inc. (US) 2022-02-23 EP claimed
US-20260138121-A1 SUPPORTED NICKEL-COPPER CATALYST FOR DEHYDROGENATION AND HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS CHEVRON U S A INC (US) 2026-05-21 US disclosed
EP-0365539-A1 HUMAN LEUCOCYTE ELASTASE INHIBITOR COMPOUNDS AUSTRALIAN COMMERCIAL RESEARCH & DEVELOPMENT LIMITED (AU) 1990-05-02 EP disclosed
WO-1988010258-A1 HUMAN LEUCOCYTE ELASTASE INHIBITOR COMPOUNDS LA TROBE UNIVERSITY (AU) 1988-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260138121-A1 SUPPORTED NICKEL-COPPER CATALYST FOR DEHYDROGENATION AND HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS NUDC, SOD1, TIMM10 ALOX15 2717/4885SMN1; SMN2 356/4885MAPT 2497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.